A Flight to Quality Is Reshaping ABA Dealmaking in 2026
Deal volume has rebounded and private equity is back, but buyers are paying premium prices only for clinically strong, well-run providers, and walking past the Medicaid-dependent, fast-grown operators that defined the last…